BDBM249384 US9464081, 17
SMILES: [#7]-[#6](=O)-c1nn(-[#6]-[#6](=O)-[#7]-2-[#6@@H]-3-[#6]-[#6@@H]-3-[#6]-[#6@H]-2-[#6](=O)-[#7]-[#6]\[#6](F)=[#6]-2\[#6]-[#6]-[#6]-[#6]-2)c2ccccc12
InChI Key: InChIKey=HNMJNQOQXAYCNO-ZMYBRWDISA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complement factor D (Homo sapiens (Human)) | BDBM249384 (US9464081, 17) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 128 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Novartis AG US Patent | Assay Description Method 1: Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compoun... | US Patent US9464081 (2016) BindingDB Entry DOI: 10.7270/Q2PN94K2 | |||||||||||
More data for this Ligand-Target Pair |